|
C10ORF18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.134020E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.117660E-02 |
| Normal-vs-Stage2 |
1.346450E-01 |
| Normal-vs-Stage3 |
2.812200E-01 |
| Normal-vs-Stage4 |
3.612100E-02 |
| Stage1-vs-Stage2 |
8.939400E-01 |
| Stage1-vs-Stage3 |
1.895970E-01 |
| Stage1-vs-Stage4 |
5.316600E-01 |
| Stage2-vs-Stage3 |
4.590600E-01 |
| Stage2-vs-Stage4 |
5.597600E-01 |
| Stage3-vs-Stage4 |
1.739790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.475900E-03 |
| Normal-vs-AfricanAmerican |
4.668000E-01 |
| Normal-vs-Asian |
3.292200E-01 |
| Caucasian-vs-AfricanAmerican |
2.017600E-01 |
| Caucasian-vs-Asian |
9.902200E-01 |
| AfricanAmerican-vs-Asian |
6.066400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.205700E-02 |
| Normal-vs-Female |
1.998910E-03 |
| Male-vs-Female |
9.462400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.036600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.116800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.921800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.207400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.292820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.410000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.647800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.090800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.657000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.193400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.656400E-02 |
| Normal-vs-Grade 2 |
3.116200E-03 |
| Normal-vs-Grade 3 |
9.387700E-02 |
| Normal-vs-Grade 4 |
2.401600E-01 |
| Grade 1-vs-Grade 2 |
5.548600E-01 |
| Grade 1-vs-Grade 3 |
2.201200E-01 |
| Grade 1-vs-Grade 4 |
3.217400E-01 |
| Grade 2-vs-Grade 3 |
1.155830E-01 |
| Grade 2-vs-Grade 4 |
5.199200E-01 |
| Grade 3-vs-Grade 4 |
8.432400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.46490000000477E-05 |
| Normal-vs-ccB subtype |
4.985400E-01 |
| ccA subtype-vs-ccB subtype |
2.172900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.521740E-02 |
| Normal-vs-N1 |
2.297200E-01 |
| N0-vs-N1 |
7.592200E-01 |
|
|
